Literature DB >> 15572184

Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.

Faith Dickerson1, John J Boronow, Cassie Stallings, Andrea E Origoni, Sara K Cole, Robert H Yolken.   

Abstract

Cognitive dysfunction is an important feature of schizophrenia and bipolar disorder. There is uncertainty about the relative magnitude of cognitive deficits in these disorders. We evaluated a total of 446 individuals: 229 with schizophrenia, 117 with bipolar disorder, and 100 controls without a history of psychiatric disorder. All participants were administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), a cognitive screening battery that evaluated immediate verbal memory, visuospatial/constructional abilities, attention, language, and delayed memory. A comparison of the three groups showed significant differences on the RBANS total score and all of the measured domains. In all of the comparisons, the schizophrenia group obtained the lowest scores, followed by the bipolar disorder group, and then the individuals without psychiatric disorder. In an analysis of covariance of RBANS total scores with the patient samples, the difference between schizophrenia and bipolar disorder remained significant after controlling for a range of demographic and clinical variables. Both schizophrenia and bipolar disorder are associated with significant cognitive impairments, but those in schizophrenia are more severe. Cognitive deficits may be an appropriate target of treatment interventions in these disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15572184     DOI: 10.1016/j.psychres.2004.07.002

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  44 in total

1.  Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.

Authors:  Xiang Yang Zhang; Jun Liang; Da Chun Chen; Mei Hong Xiu; Fu De Yang; Therese A Kosten; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2012-01-26       Impact factor: 4.530

2.  Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.

Authors:  Colin A Depp; David J Moore; David Sitzer; Barton W Palmer; Lisa T Eyler; Scott Roesch; Barry D Lebowitz; Dilip V Jeste
Journal:  J Affect Disord       Date:  2007-01-16       Impact factor: 4.839

3.  Correlates of real world executive dysfunction in bipolar I disorder.

Authors:  Amy T Peters; Andrew D Peckham; Jonathan P Stange; Louisa G Sylvia; Natasha S Hansen; Stephanie Salcedo; Scott L Rauch; Andrew A Nierenberg; Darin D Dougherty; Thilo Deckersbach
Journal:  J Psychiatr Res       Date:  2014-03-02       Impact factor: 4.791

4.  Improving Health Outcomes for Patients with Depression: A Population Health Imperative. Report on an Expert Panel Meeting.

Authors:  Janice L Clarke; Alexis Skoufalos; Alice Medalia; A Mark Fendrick
Journal:  Popul Health Manag       Date:  2016-09       Impact factor: 2.459

5.  Is cognitive impairment in schizophrenia ready for diagnostic prime time?

Authors:  James M Gold
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

6.  Cognitive function and competitive employment in schizophrenia: relative contribution of insight and psychopathology.

Authors:  Michela Giugiario; Barbara Crivelli; Cinzia Mingrone; Cristiana Montemagni; Mara Scalese; Monica Sigaudo; Giuseppe Rocca; Paola Rocca
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-31       Impact factor: 4.328

7.  RBANS Validity Indices: a Systematic Review and Meta-Analysis.

Authors:  Robert D Shura; Timothy W Brearly; Jared A Rowland; Sarah L Martindale; Holly M Miskey; Kevin Duff
Journal:  Neuropsychol Rev       Date:  2018-05-16       Impact factor: 7.444

8.  Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.

Authors:  Xiang Y Zhang; Da C Chen; Mei H Xiu; Fu D Yang; Yunlong Tan; Xingguang Luo; Lingjun Zuo; Therese A Kosten; Thomas R Kosten
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

9.  Resting state functional connectivity of five neural networks in bipolar disorder and schizophrenia.

Authors:  Daniel Mamah; Deanna M Barch; Grega Repovš
Journal:  J Affect Disord       Date:  2013-03-13       Impact factor: 4.839

Review 10.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.